The Global Biochips
Market, By Product Type (DNA Chips, Protein Chips, Lab-on-a-Chip, and
Others), By Technology (Microfluidics and Microarray), By Application
(Genomics, Proteomics, Drug Discovery & Development, and In Vitro
Diagnostics), and By Region (North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa) was valued at US$ 7,026.4 million in 2016 and
is projected to exhibit a CAGR of 16.2% over the forecast period (2017 – 2025).
Growth of the biochips market is
attributed to increasing adoption of biochips for various research
applications, applications in personalized medicine, applications in cancer
therapies, and ongoing research and development by leading players to enhance
technologies in biochips. Manufacturers
are focusing on introducing innovative biochips in line with needs and demands
of customers. For instance, Micralyne, Inc. launched Silicon MicraFluidics
technology, a line of standardized microfluidic process technologies, which
enables rapid design and deployment of microfluidic-based products in February
2018. InDevR Inc. launched a FluChip-8G technology in February 2018, which can
be used only for research purposes. InDevR Inc.’s FluChip-8G Influenza A+B
Assay is based on amplification technology, DNA microarrays, and machine
learning. Furthermore, in December 2017, 3dbiosurfaces and STRATEC Consumables
GmbH launched 3D NS-NC slide, which is used for proteomics studies. In November
2017, Micronit Microtechnologies, Axxicon, and Helvoet collaborated to meet
increasing demand for high volume polymer microfluidic products worldwide.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1146
Browse 40 Market Data Tables and
34 Figures spread through 152 Pages and in-depth TOC on Biochips Market, by
Product Type (DNA Chips, Protein Chips, Lab-on-a-Chip, and Others), By
Technology (Microfluidics and Microarray), By Application (Genomics,
Proteomics, Drug Discovery & Development, and In Vitro Diagnostics), and
Region (North America, Latin America, Europe, Asia Pacific, Middle East, and,
Africa) - Global Forecast to 2025
Active research and development
of biochips technology such as microfluidics and microarrays is expected to
fuel growth of the global biochips market. A new biochip-based blood test has
been developed to detect elevated risk for Alzheimer’s disease and pairing this
test with medical and family history can advance personalized medicine
significantly. Researchers from Randox Laboratories and Medical University of
Vienna presented the results of this test at the 68th American Association for
Clinical Chemistry (AACC) scientific meeting in 2016. Furthermore, an
Israel-based company, NovellusDx, used biochip technology to recreate a
patient’s genetic map to identify gene mutations driving the cancer in August
2017. This technology can help oncologists to choose the right cancer therapy
for patients. In February 2018, researchers from Osaka University, Japan developed
a diagnostic lab-on-a-chip, which has combined terahertz waves with a
microfluidic device. Integration of recent innovations with the existing
biochip technologies is expected to further improve the effectiveness of these
products.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/biochips-market-1146
Key Takeaways of the Biochips
Market:
The global biochips market is
expected to exhibit a CAGR of 16.2% over the forecast period (2017 – 2025),
owing to continuous product offerings by key players such as Thermo Fisher
Scientific, and Illumina, Inc. in biochips market
Increasing competition in the
market has led to increasing focus of key players on continuous product
development, in order to enhance their market share. This is expected to aid in
market growth over the forecast period.
DNA Chips segment is expected to
dominate the global biochips market over the forecast period at a CAGR of
16.2%, owing to applications in transcriptomes and proteomes, diagnosis of
diseases, and others
Microarray technology is expected
to account for maximum share percentage over the forecast period due to
application in diagnosis, drug discovery and development, and biotechnology
Major players operating in the
biochips market include Randox Laboratories, Fluidigm Corporation, Abbott
Laboratories, Agilent Technologies, Inc., ThermoFisher Scientific, Inc.,
Bio-Rad Laboratories, Inc., Illumina, Inc., and PerkinElmer, Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1146
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment